Más de 1.500 muertos por el brote de ébola en la República Democrática del Congo

The Democratic Republic of Congo’s (DRC) current Ebola outbreak has become the world’s second-largest ever, surpassing the scale of the country’s deadliest epidemic between 2018 and 2020. As of late July 2026, authorities have confirmed 3,532 cases, including 1,556 deaths, across five provinces. This figure marks a dramatic increase from just over 2,000 cases recorded on July 15, highlighting the unprecedented speed of transmission. The outbreak is centered in Ituri province, located in northeastern DRC, near the borders with South Sudan and Uganda. Health officials acknowledge that the actual number of infections could be significantly higher due to challenges in tracking and reporting. The Bundibugyo strain of the Ebola virus is responsible for the current outbreak, and unlike past epidemics, there is currently no approved vaccine or treatment available for this specific variant. However, vaccine development is progressing, with the WHO citing a candidate from Singapore-based Hilleman Laboratories as the most promising option. Another experimental vaccine, developed by the University of Oxford, is also in advanced stages of testing, with the first human trial recently completed. Despite these developments, experts caution that widespread availability of effective treatments will likely take several more months. The rapid spread of the virus has raised alarm among health professionals, who describe the current outbreak as the fastest-growing in history. According to the Africa Centres for Disease Control and Prevention, the death toll within the first three months of the outbreak has exceeded that of all previous Ebola outbreaks combined. The mortality rate stands at approximately 44 percent, meaning nearly half of all confirmed cases result in fatalities. This high fatality rate underscores the severity of the situation and the urgent need for improved containment measures. Conflict and political instability further complicate efforts to control the outbreak. The affected regions, particularly North Kivu and South Kivu, remain under the influence of the Rwanda-backed M23 rebel group, which has hindered access to some communities. This has made it difficult for health workers to reach patients and conduct necessary contact tracing. Additionally, misinformation and lack of public awareness continue to pose significant barriers to effective response strategies. Local populations often delay seeking medical help until symptoms become severe, reducing their chances of survival. International organizations and local health authorities have called for increased support and resources to combat the crisis. The World Health Organization declared a public health emergency in May, emphasizing the need for immediate action. Experts stress that without substantial improvements in healthcare infrastructure, patient care, and community engagement, the outbreak could persist well into the coming year. The situation has prompted calls for greater international collaboration, with many urging donors and governments to provide additional funding and logistical assistance. As the outbreak expands, concerns grow about its potential to spill over into neighboring countries. With cases already reported in multiple provinces, including those bordering South Sudan, the risk of regional spread remains high. Public health officials are working tirelessly to expand testing capabilities, improve isolation facilities, and enhance communication with local communities. While the development of new vaccines offers hope, the immediate challenge remains ensuring that affected populations receive timely and adequate care. The situation continues to evolve, with health authorities monitoring the outbreak closely and adjusting strategies as needed.